Excision and adjuvant treatment to prevent keloid recurrence. – a systematic review of prospective, clinical, controlled trials

References

• Walliczek U, Engel S, Weiss C, et al. Clinical outcome and quality of life after a multimodal therapy approach to ear keloids. JAMA Facial Plast Surg. 2015;17(5):333–339.
   PubMed Web of Science ®Google Scholar
• Nangole FW, Agak GW. Keloid pathophysiology: fibroblast or inflammatory disorders?. In: JPRAS open. vol 22, Amsterdam; Elsevier Ltd.; 2019. p. 44–54.
   Google Scholar
• Ud-Din S, Bayat A. Keloid scarring or disease: Unresolved quasi-neoplastic tendencies in the human skin. In: Wound repair and regeneration. Oxford: Wiley; 2020.
   Google Scholar
• Shih B, Bayat A. Genetics of keloid scarring. Archives of dermatological research. vol 302. Berlin: Springer; 2010. p. 319–339.
   Google Scholar
• Glass DA. Current understanding of the genetic causes of keloid formation. J Investig Dermatol Symp Proc. 2017;18(2):S50–S3.
   PubMedGoogle Scholar
• Taylor SC, Burgess CM, Callender VD. Safety of nonanimal stabilized hyaluronic acid dermal fillers in patients with skin of color: a randomized, evaluator-blinded comparative trial. Dermatol Surg. 2009;35(Supplement 2):1653–1660.
   PubMed Web of Science ®Google Scholar
• Belie O, AO Ugburo BM. Demographic and clinical characteristics of keloids in an urban center in Sub-Sahara Africa. Niger J Clin Pract. 2020;22:1049.
   Web of Science ®Google Scholar
• Keeling BH, Whitsitt J, Liu A, et al. Keloid removal by shave excision with adjuvant external beam radiation therapy. Dermatol Surg. 2015;41(8):989–992.
   PubMed Web of Science ®Google Scholar
• Ashcroft KJ, Syed F, Bayat A. Site-specific keloid fibroblasts alter the behaviour of normal skin and normal scar fibroblasts through paracrine signalling. PLOS One. 2013;8(12):e75600.
   PubMed Web of Science ®Google Scholar
• Luo S, Benathan M, Raffoul W, et al. Abnormal balance between proliferation and apoptotic cell death in fibroblasts derived from keloid lesions. In: Plastic and reconstructive surgery. vol. 107. Baltimore (MD): Lippincott Williams and Wilkins; 2001. p. 87–96.
   Google Scholar
• Sidgwick GP, Bayat A. Extracellular matrix molecules implicated in hypertrophic and keloid scarring. J Eur Acad Dermatol Venereol. 2012;26(2):141–152.
   PubMed Web of Science ®Google Scholar
• Berman B, Maderal A, Raphael B. Keloids and hypertrophic scars: pathophysiology, classification, and treatment. In: Dermatologic surgery. vol 43. New York (NY): Elsevier Science Pub Co; 2017. p. S3–S18.
   Google Scholar
• Al-Attar A, Mess S, Thomassen JM, et al. Keloid pathogenesis and treatment. Plast Reconstr Surg. 2006;117(1):286–300.
   PubMed Web of Science ®Google Scholar
• Kelly AP. Medical and surgical therapies for keloids. Dermatol Ther. 2004;17(2):212–218.
   PubMedGoogle Scholar
• Ogawa R, Tosa M, Dohi T, et al. Surgical excision and postoperative radiotherapy for keloids. Scars Burn Heal. 2019;5:2059513119891113.
   Google Scholar
• Berman B, Bieley HC. Adjunct therapies to surgical management of keloids. Dermatol Surg. 1996;22:126–130.
   PubMed Web of Science ®Google Scholar
• Hatoko M, Shiba A, Okazaki T, et al. Earlobe reconstruction using. Dermatol Surg. 1998;24(2):257–261.
   PubMed Web of Science ®Google Scholar
• Emad M, Omidvari S, Dastgheib L, et al. Surgical excision and immediate postoperative radiotherapy versus cryotherapy and intralesional steroids in the management of keloids: a prospective clinical trial. Med Princ Pract. 2010;19(5):402–405.
   PubMed Web of Science ®Google Scholar
• Al Aradi IK, Alawadhi SA, Alkhawaja FA, et al. Earlobe keloids: a pilot study of the efficacy of keloidectomy with core fillet flap and adjuvant intralesional corticosteroids. Dermatol Surg. 2013;39(10):1514–1519.
   PubMed Web of Science ®Google Scholar
• Hayashi T, Furukawa H, Oyama A, et al. A new uniform protocol of combined corticosteroid injections and ointment application reduces recurrence rates after surgical keloid/hypertrophic scar excision. Dermatol Surg. 2012;38(6):893–897.
   PubMed Web of Science ®Google Scholar
• Sclafani AP, Gordon L, Chadha M, et al. Prevention of earlobe keloid recurrence with postoperative corticosteroid injections versus radiation therapy: a randomized, prospective study and review of the literature. Dermatol Surg. 1996;22:569–574.
   PubMed Web of Science ®Google Scholar
• Jiang P, Geenen M, Siebert FA, et al. Efficacy and the toxicity of the interstitial high-dose-rate brachytherapy in the management of recurrent keloids: 5-year outcomes. Brachytherapy. 2018;17(3):597–600.
   PubMed Web of Science ®Google Scholar
• Bashir MM, Ahmad H, Yousaf N, et al. Comparison of single intra operative versus an intra operative and two post operative injections of the triamcinolone after wedge excision of keloids of helix. J Pak Med Assoc. 2015;65(7):737–741.
   PubMed Web of Science ®Google Scholar
• Li W, Wang Y, Wang X, et al. A keloid edge precut, preradiotherapy method in large keloid skin graft treatment. Dermatologic Surg. 2014;40(1):52–57.
   PubMed Web of Science ®Google Scholar
• Litrowski N, Boullie MC, Dehesdin D, et al. Treatment of earlobe keloids by surgical excision and cryosurgery. J Eur Acad Dermatol Venereol. 2014;28(10):1324–1331.
   PubMed Web of Science ®Google Scholar
• Ogawa R, Huang C, Akaishi S, et al. Analysis of surgical treatments for earlobe keloids: Analysis of 174 lesions in 145 patients. Plast Reconstr Surg. 2013;132(5):818–825.
   Web of Science ®Google Scholar
• Park TH, Chang CH. Early postoperative magnet application combined with hydrocolloid dressing for the treatment of earlobe keloids. Aesthetic Plast Surg. 2013;37(2):439–444.
   PubMed Web of Science ®Google Scholar
• D'Andrea F, Brongo S, Ferraro G, et al. Prevention and treatment of keloids with intralesional verapamil. Dermatology. 2002;204(1):60–62.
   PubMed Web of Science ®Google Scholar
• Verhiel S, De Grzymala AP, Van Der Hulst R. Mechanism of action, efficacy, and adverse events of calcium antagonists in hypertrophic scars and keloids: a systematic review. Dermatol Surg. 2015;41(12):1343–1350.
   PubMed Web of Science ®Google Scholar
• Hatamipour E, Mehrabi S, Hatamipour M, et al. Effects of combined intralesional 5- fluorouracil and topical silicone in prevention of keloids; a double blind randomized clinical trial study. Acta Med Iran. 2011;49(3):127–130.
   PubMedGoogle Scholar
• Berman B, Perez OA, Konda S, et al. A review of the biologic effects, clinical efficacy, and safety of silicone elastomer sheeting for hypertrophic and keloid scar treatment and management. Dermatologic Surg. 2007;33(11):1291–1303.
   PubMed Web of Science ®Google Scholar
• Berman B, Villa A. Imiquimod 5% cream for keloid management. Dermatologic Surg. 2003;29(10):1050–1051.
   PubMed Web of Science ®Google Scholar
• Stashower ME. Successful treatment of earlobe keloids with imiquimod after tangential shave excision. Dermatologic Surg. 2006;32(3):380–386.
   PubMed Web of Science ®Google Scholar
• Martin-García RF, Busquets AC. Postsurgical use of imiquimod 5% cream in the prevention of earlobe keloid recurrences: results of an open-label, pilot study. Dermatol Surg. 2005;31(11 Pt 1):1394–1398.
   PubMed Web of Science ®Google Scholar
• Cação FM, Tanaka V, Messina MCDL. Failure of imiquimod 5% cream to prevent recurrence of surgically excised trunk keloids. Dermatol Surg. 2009;35(4):629–633.
   PubMed Web of Science ®Google Scholar
• PATEL PJ, SKINNER RB. Letter: experience with keloids after excision and application of 5% Imiquimod cream. Dermatologic Surg. 2006;32(3):462–462.
   PubMed Web of Science ®Google Scholar
• Chandawarkar RY, Piorkowski J, Amjad I, et al. Combination therapy of a large, recurrent keloid. Dermatologic Surg. 2007;33(2):229–235.
   PubMed Web of Science ®Google Scholar
• Jones ME, McLane J, Adenegan R, et al. Advancing keloid treatment: a novel multimodal approach to ear keloids. Dermatol Surg. 2017;43(9):1164–1169.
   PubMed Web of Science ®Google Scholar
• Higgins JPT, Thomas J, Chandler J, et al. Cochrane handbook for systematic reviews of interventions. 2nd ed. Chichester (UK): John Wiley & Sons; 2019.
   Google Scholar
• Essential evidence plus, levels of evidence. John Wiley & Sons. [cited 2020 Jul 17]. https://www.essentialevidenceplus.com/product/ebm_loe.cfm?show=oxford.
   Google Scholar
• Howick J, Chalmers I, Glasziou P, et al. The 2011 Oxford CEBM levels of evidence (Introductory Document) [Internet]. Oxford Center for Evidence-Based Medicine; 2011 [cited 2020 Jul 12]. https://www.cebm.net/index.aspx?o=5653.
   Google Scholar
• Howick J, Chalmers I, Glasziou P, et al. Explanation of the 2011 Oxford Centre for Evidence-Based Medicine (OCEBM) levels of evidence (background document). Oxford Center for Evidence-Based Medicine. [cited 2022 Jul 7]. https://www.cebm.ox.ac.uk/resources/levels-of-evidence/ocebm-levels-of-evidence.
   Google Scholar
• Howick J, Chalmers I, Glasziou P, et al. The Oxforf levels of evidence 2 [Internet]. Oxford Center for Evidence-Based Medicine; 2011 [cited 2020 Jul 12]. https://www.cebm.net/index.aspx?o=5653.
   Google Scholar
• Karmisholt KE, Wenande E, Thaysen-Petersen D, et al. Early intervention with non-ablative fractional laser to improve cutaneous scarring-a randomized controlled trial on the impact of intervention time and fluence levels. Lasers Surg Med. 2018;50(1):28–36.
   PubMed Web of Science ®Google Scholar
• Karmisholt KE, Banzhaf CA, Glud M, et al. Laser treatments in early wound healing improve scar appearance: a randomized split-wound trial with nonablative fractional laser exposures vs. untreated controls. Br J Dermatol. 2018;179(6):1307–1314.
   PubMed Web of Science ®Google Scholar
• Davidson S, Aziz N, Rashid RM, et al. A primary care perspective on keloids. Medscape J Med. 2009;11(1):18.
   PubMedGoogle Scholar
• Muir IFK. On the nature of keloid and hypertrophic scars. Br J Plast Surg. 1990;43(1):61–69.
   PubMedGoogle Scholar